Gu et al. [105] revealed that Withaferin A activated SIRT3, which suppressed liver fibrosis via upregulating the activity of antioxidant enzymes such as catalase (CAT), superoxide dismutase, and glutathione peroxidase (GPx). Here, SIRT3 is linked to Hepatic fibrosis.